Drug interaction software and the risk of using ceftriaxone with therapeutic hemapheresis.
Motroni
Mathew
M
Reilly
Cynthia
C
D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001781:Blood Component Removal / Q000379:methods*; D002443:Ceftriaxone / Q000009:adverse effects*; D004347:Drug Interactions; D006801:Humans; D012306:Risk; D012984:Software; D014481:United States; D014486:United States Food and Drug Administration
D000900:Anti-Bacterial Agents; D002443:Ceftriaxone